Gain a deeper understanding of oligonucleotide analysis, together with optimized LC-MS techniques for effective development, characterization, and quantification.

Day Two explores advanced MS strategies for proteomics, glycoproteins, bioreactor monitoring, and single-cell metabolomics, featuring experts from pharma and academia.

AbbVie presents the development of an Open-Access LC-MS platform for medicinal chemistry projects, enabled by Agilent OpenLab CDS SDK integration.

Join Phenomenex’s Koen Askamp to explore normal-phase HPLC: how it works, when to apply it, key differences from reversed-phase, and how to overcome typical challenges.

Discover how to make changes to the LC system to increase its biocompatibility.

The Control Panel is the gatekeeper to the system. Explore several software features that have been designed to help you from user authentication to configure system or set-up an Acquisition Method to reports.

Discover how to optimize Oasis HLB SPE workflows and automate method development with Andrew+ Robot to boost recovery, reduce variability, and accelerate timelines.

Explore advanced tools for high-concentration antibody formulations with experts from TA Instruments and Wyatt Technology. Learn how DLS, SLS, and RS-DSC assess stability.

Day one explores next-gen technologies in metabolomics, proteomics, CRO automation, and electrophoresis, with global experts shaping the future of analytical science.

Join Prof. James McCullagh to explore how IC-MS enhances metabolomics by improving the analysis of polar and ionic metabolites, enabling accurate and reproducible pathway studies.